Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 171

    1.

    Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity.

    Hsueh WC, Cole SA, Shuldiner AR, Beamer BA, Blangero J, Hixson JE, MacCluer JW, Mitchell BD.

    Diabetes Care. 2001 Apr;24(4):672-7.PMID: 11315829 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans.

    Cole SA, Mitchell BD, Hsueh WC, Pineda P, Beamer BA, Shuldiner AR, Comuzzie AG, Blangero J, Hixson JE.

    Int J Obes Relat Metab Disord. 2000 Apr;24(4):522-4.PMID: 10805513 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study.

    Kao WH, Coresh J, Shuldiner AR, Boerwinkle E, Bray MS, Brancati FL; Atherosclerosis Risk in Communities Study.

    Diabetes. 2003 Jun;52(6):1568-72.PMID: 12765972 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus.

    Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, Deeb SS, Amouyel P.

    Int J Obes Relat Metab Disord. 2000 Feb;24(2):195-9.PMID: 10702770 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus]

    Fu M, Chen H, Li X, Li J, Wu B, Cheng L, Cai M, Fu Z.

    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Jun;19(3):234-8. Chinese. PMID: 12048686 [PubMed - indexed for MEDLINE]Related articles

    7.

    TRP64ARG beta 3-adrenergic receptor and obesity in Mexican Americans.

    Silver K, Mitchell BD, Walston J, Sorkin JD, Stern MP, Roth J, Shuldiner AR.

    Hum Genet. 1997 Dec;101(3):306-11.PMID: 9439659 [PubMed - indexed for MEDLINE]Related articles

    9.

    The beta 3-adrenergic receptor gene and obesity in a population sample of African Americans.

    Lowe Jr WL, Rotimi CN, Luke A, Guo X, Zhu X, Comuzzie AG, Schuh TS, Halbach S, Kotlar TJ, Cooper RS.

    Int J Obes Relat Metab Disord. 2001 Jan;25(1):54-60.PMID: 11244458 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pro12Ala mutation in the peroxisome proliferator-activated receptor gamma2 (PPARgamma2) and severe obesity: a case-control study.

    Vaccaro O, Mancini FP, Ruffa G, Sabatino L, Colantuoni V, Riccardi G.

    Int J Obes Relat Metab Disord. 2000 Sep;24(9):1195-9.PMID: 11033990 [PubMed - indexed for MEDLINE]Related articles

    11.

    A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.

    Swarbrick MM, Chapman CM, McQuillan BM, Hung J, Thompson PL, Beilby JP.

    Eur J Endocrinol. 2001 Mar;144(3):277-82.PMID: 11248748 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is associated with increased plasma leptin levels in obese Chinese women.

    Lin SY, Sheu WH, Lee WJ, Song YM, Chen YT.

    Zhonghua Yi Xue Za Zhi (Taipei). 1999 Sep;62(9):569-76.PMID: 10502846 [PubMed - indexed for MEDLINE]Related articles

    13.

    Analysis of candidate genes in Polish families with obesity.

    Malczewska-Malec M, Wybranska I, Leszczynska-Golabek I, Partyka L, Hartwich J, Jabrocka A, Kiec-Wilk B, Kwasniak M, Motyka M, Dembinska-Kiec A.

    Clin Chem Lab Med. 2004 May;42(5):487-93.PMID: 15202783 [PubMed - indexed for MEDLINE]Related articles

    14.

    Single nucleotide variants in the beta2-adrenergic and beta3-adrenergic receptor genes explained 18.3% of adolescent obesity variation.

    Park HS, Kim Y, Lee C.

    J Hum Genet. 2005;50(7):365-9. Epub 2005 Jun 15.PMID: 15959859 [PubMed - indexed for MEDLINE]Related articles

    15.

    LEPR p.Q223R, beta3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjects.

    Duarte SF, Francischetti EA, Genelhu VA, Cabello PH, Pimentel MM.

    Genet Mol Res. 2007 Oct 5;6(4):1035-43.PMID: 18273796 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.

    González Sánchez JL, Serrano Ríos M, Fernández Perez C, Laakso M, Martínez Larrad MT.

    Eur J Endocrinol. 2002 Oct;147(4):495-501.PMID: 12370112 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men.

    Ek J, Urhammer SA, Sørensen TI, Andersen T, Auwerx J, Pedersen O.

    Diabetologia. 1999 Jul;42(7):892-5.PMID: 10440134 [PubMed - indexed for MEDLINE]Related articles

    18.

    The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.

    Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, Oeth P, Mohlke KL, Valle TT, Ehnholm C, Buchanan TA, Bergman RN, Collins FS, Boehnke M, Tuomilehto J.

    Diabetes. 2001 Apr;50(4):886-90.PMID: 11289057 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Association of beta3 adrenergic receptor and peroxisome proliferator-activated receptor gamma 2 polymorphisms with insulin sensitivity: a twin study.

    Chen TJ, Ji CY, Zheng XY, Hu YH.

    Biomed Environ Sci. 2007 Apr;20(2):99-105.PMID: 17624182 [PubMed - indexed for MEDLINE]Related articles

    20.

    Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects.

    Kawasaki I, Tahara H, Emoto M, Shoji T, Shioji A, Okuno Y, Inaba M, Nishizawa Y.

    Osaka City Med J. 2002 Jun;48(1):23-8.PMID: 12375694 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data